UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 214

Sortiert nach

Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease

Neuropsychopharmacology (New York, N.Y.), 2019-04, Vol.44 (5), p.837-849

2019

Volltextzugriff (PDF)

Antidepressants and prolonged stress in rats modulate CAM-L1, laminin, and pCREB, implicated in neuronal plasticity

Neurobiology of disease, 2005-11, Vol.20 (2), p.432-441

2005

Volltextzugriff (PDF)

Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients

Molecular psychiatry, 2013-10, Vol.18 (10), p.1067-1076

2013

Volltextzugriff (PDF)

Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?

Journal of neurochemistry, 1994-09, Vol.63 (3), p.793-807

1994

Volltextzugriff (PDF)

Psychotropic and neurological medication effects on mitochondrial complex I and IV in rodent models

European neuropsychopharmacology, 2019-09, Vol.29 (9), p.986-1002

2019

Volltextzugriff (PDF)

State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia

Molecular psychiatry, 2002-01, Vol.7 (9), p.995-1001

2002

Volltextzugriff (PDF)

Structural Characteristics of Human Substantia Nigra Neuromelanin and Synthetic Dopamine Melanins

Journal of neurochemistry, 2000-12, Vol.75 (6), p.2583-2589

2000

Volltextzugriff (PDF)

Influence of neuromelanin on oxidative pathways within the human substantia nigra

Neurotoxicology and Teratology, 2002-09, Vol.24 (5), p.621-628

2002

Volltextzugriff (PDF)

Complex I impairments in schizophrenia; a complex story

European neuropsychopharmacology, 2016-10, Vol.26, p.S357-S357

2016

Volltextzugriff (PDF)

Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders

Biochemical pharmacology, 2004-05, Vol.67 (10), p.1965-1974

2004

Volltextzugriff (PDF)

The possible role of iron in the etiopathology of parkinson's disease

Movement disorders, 1993, Vol.8 (1), p.1-12

1993

Volltextzugriff (PDF)

Induced pluripotent stem cells from hair follicles as a cellular model for neurodevelopmental disorders

Stem cell research, 2012, Vol.8 (1), p.134-140

2012

Volltextzugriff (PDF)

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

Acta neurologica Scandinavica, 1989-11, Vol.80 (s126), p.47-54

1989

Volltextzugriff (PDF)

The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons

Journal of neurochemistry, 1991-04, Vol.56 (4), p.1441-1444

1991

Volltextzugriff (PDF)

Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in Rats

Journal of neurochemistry, 1991-12, Vol.57 (6), p.2133-2135

1991

Volltextzugriff (PDF)

P.2.016 A possible involvement of opioid degrading enzymes in individual reactivity to acute traumatic stress

European neuropsychopharmacology, 2010, Vol.20, p.S41-S42

2010

Volltextzugriff (PDF)

Role of iron and iron chelation in dopaminergic-induced neurodegeneration: Implication for Parkinson's disease

Annals of neurology, 1992, Vol.32 (S1), p.S105-S110

1992

Volltextzugriff (PDF)

Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine

Journal of neurochemistry, 2002-12, Vol.83 (6), p.1241-1251

Ben‐Shachar, Dorit

2002

Volltextzugriff (PDF)

P.1.06 Impaired mitochondrial respiration due to dopamine inhibition of complex I activity: implication to schizophrenia

European neuropsychopharmacology, 2008, Vol.18, p.s6-s7

2008

Volltextzugriff (PDF)

Mitochondrial complex i subunits expression is altered in schizophrenia: a postmortem study

Biological psychiatry (1969), 2004-04, Vol.55 (7), p.676-684

2004

Volltextzugriff (PDF)

Transcranial magnetic stimulation induces alterations in brain monoamines

Journal of Neural Transmission, 1997-01, Vol.104 (2-3), p.191-197

1997

Volltextzugriff (PDF)

P.1.09 DA affects mitochondrial function via its interaction with complex I: implications to schizophrenia

European neuropsychopharmacology, 2007, Vol.17, p.S9-S10

2007

Volltextzugriff (PDF)

ATF2, A Member of the CREB ATF Family of Transcription Factors, in Chronic Stress and Consequent to Antidepressant Treatment: Animal Models and Human Post-Mortem Brains

Neuropsychopharmacology (New York, N.Y.), 2004-03, Vol.29 (3), p.589-597

2004

Volltextzugriff (PDF)

P.1.10 A complex norepinephrine and glucocorticoid intercellular interaction: relevance to plasticity hypothesis of depression

European neuropsychopharmacology, 2007, Vol.17, p.S10-S11

2007

Volltextzugriff (PDF)

Mitochondria, Synaptic Plasticity, And Schizophrenia

Disorders of Synaptic Plasticity and Schizophrenia, 2004, Vol.59, p.273-296

2004

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(205)
Mit Volltextzugriff
(183)

Publikationsform

Sprache

Englisch
(214)
Japanisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease

Antidepressants and prolonged stress in rats modulate CAM-L1, laminin, and pCREB, implicated in neuronal plasticity

Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients

Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?

Psychotropic and neurological medication effects on mitochondrial complex I and IV in rodent models

State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia

Structural Characteristics of Human Substantia Nigra Neuromelanin and Synthetic Dopamine Melanins

Influence of neuromelanin on oxidative pathways within the human substantia nigra

Complex I impairments in schizophrenia; a complex story

Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders

The possible role of iron in the etiopathology of parkinson's disease

Induced pluripotent stem cells from hair follicles as a cellular model for neurodevelopmental disorders

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons

Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in Rats

P.2.016 A possible involvement of opioid degrading enzymes in individual reactivity to acute traumatic stress

Role of iron and iron chelation in dopaminergic-induced neurodegeneration: Implication for Parkinson's disease

Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine

P.1.06 Impaired mitochondrial respiration due to dopamine inhibition of complex I activity: implication to schizophrenia

Mitochondrial complex i subunits expression is altered in schizophrenia: a postmortem study

Transcranial magnetic stimulation induces alterations in brain monoamines

P.1.09 DA affects mitochondrial function via its interaction with complex I: implications to schizophrenia

ATF2, A Member of the CREB ATF Family of Transcription Factors, in Chronic Stress and Consequent to Antidepressant Treatment: Animal Models and Human Post-Mortem Brains

P.1.10 A complex norepinephrine and glucocorticoid intercellular interaction: relevance to plasticity hypothesis of depression

Mitochondria, Synaptic Plasticity, And Schizophrenia

Suchergebnisse filtern